Skip to main content

Table 1 Participant demographic, clinical, and self-reported characteristics

From: Belonging, happiness, freedom and empowerment—a qualitative study of patients’ understanding of health in early rheumatoid arthritis

Number of participants (n)

31

Site of recruitment

Regional Rheumatology Specialist Outpatient Clinic/University Hospital (n)

3/28

Individual interviews (n)

31

Gender Female/Male (n)

22/9

Age (years) Median (range)

56 (38–80)

Disease Duration (months)

Median (range)

5 (3–9)

DMARD Treatment Duration (months)

Median (range)

5 (3–7)

Current DMARD treatment (n)

csDMARDs

bDMARDs

Discontinued treatment

30

8

1

Civil Status (n)

Co-habiting/Living alone

27/4

Education Level (n)

Primary School/Secondary/University

8/15/8

Employment (n)

Employed/Student/Unemployed/Retired

14/1/3/13

NRS Pain (mm)*

Median (Range)

27 (0–70)

NRS General Health (mm)*

Median (Range)

26 (0–80)

NRS Fatigue (mm)*

Median (Range)

30 (0–95)

  1. *during the past week. Range 0–100 (best to worst)
  2. Abbreviations: csDMARD(s): conventional synthetic disease-modifying anti-rheumatic drug, bDMARD: biological disease-modifying anti-rheumatic drug, NRS: numeric rating scale